Skip to main content

Podcast

Gout Lessons from the Clinic Part 3

Dr. Sheila Reyes: QD Clinic: The Highs and Lows of a Woman with Gout Dr. Jack Cush QD319 A Watched Tophus Never Resolves Dr. Eric Dein QD316: Addressing Severe Gout Flares Dr. Janet Pope QD Clinic: RA Mimics — Two Cases That Turned Out to Be Gout

DERM on RheumNow (July 2026)

The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, CTD skin disorders. dermatology drugs, biologics, andJAK inhibitors - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: - 20 yr. Tx trends in 6583 #SSc pts. 2005 to 2025 endothelin receptor antagonists & prostanoids/prostacyclins from 3% to 28%.

New, Advanced Therapies in Gout

New, Advanced Therapies in Gout explores the rapidly evolving therapeutic landscape beyond conventional urate-lowering therapy.

Systemic Burden of Gout Part 1

Dr. Robert Terkeltaub 3 New Things it Pays to Know About Gout Pathobiology Dr. Nicola Dalbeth Outcomes of Tophaceous Gout Dr. Ted Mikuls Subclinical Inflammation in Intercritical Gout Dr. Michael Pillinger Gout and Cardiovascular Disease: What's the Risk? What's the Connection?

Better Gout Management

Dr. John Fitzgerald Gout & Metabolic syndrome Dr. Karon Jatuworpruk Predicting and managing gout flares in hospitalised patients Dr. Richard Conway Bespoke Telehealth in Gout: A Missed Opportunity

Gout Advice & Tips

Dr. Robert Terkeltaub Four things you need to know about allopurinol hypersensitivity syndrome Dr. Angelo Gaffo Challenges in Gout Diagnosis Dr. Janet Pope Tips for safe use of allopurinol in patients with gout

Gout Lessons from the Clinic Part 2

Dr Janet Pope: QD Clinic: Can RA and Gout Manifest Simultaneously?  Dr. Mrinalini Dey QD312: Gout, Sepsis… or Both?  Daric Mueller, PA-C QD315: Pegloticase Immunomodulation: What’s on the Menu?  Dr. Richard Conway: QD313: Don't Presume on IL-1 in Gout 

Chikungunya Club Meeting (7.24.2026)

Dr. Jack Cush reviews the news, journal reports from the past week on RheumNow.com

Upgrading & Maximizing the Classics (Colchicine, Allopurinol, etc.)

Upgrading & Maximizing the Classics (Colchicine, Allopurinol, etc.) examines how to optimize the use of time-tested gout therapies in today's increasingly complex patients.

Seronegative RA Disease Activity (7.17.202)

Dr. Jack Cush reviews the news, journal articles and Gout features from this past week on RheumNow.com

What Lies Beneath - Uric Acid Deposition & Imaging

This webinar explores the evolving role of imaging in the diagnosis and management of gout. Our expert panel will discuss when and how to use ultrasound, dual-energy CT (DECT), crystal identification, and conventional radiography, while addressing practical questions such as the role of imaging in diagnostic uncertainty, serial disease monitoring, and whether ultrasound is changing the need for synovial fluid analysis in everyday practice.

Gout QD clinics - lessons from the Clinic QD307-QD311

QD307: Senior Year Gout https://youtu.be/_TGgcdQsfic QD308: Allopurinol for All Gout? Not Quite https://youtu.be/JAwUb-hqeFs QD309: Cellulitis Paradoxes https://youtu.be/j3feySk5wQo QD310: Gout: Is it the Journey or the Destination?

Gout Cavalcade (7.10.2026)

Dr. Jack Cush reviews the news, journal articles and regulatory decisions from the past week. July is Gout: More than Flares month. Visit https://rheumnow.com/campaign/gout-campaign-july-2026 for all of our coverage throughout July.

Gout Journal Club

Gout Journal Club will examine two influential publications: 1. "Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients with Gout" (Cipolletta et al., JAMA Internal Medicine, 2026) and 2. "Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease"(Wang et al., JAMA Internal Medicine, 2025).

Podcast Replay: Is it Time to Transition MOAs in RA?

In August, Dr. Christina Charles-Schoeman and Dr. Manish Jain will return with a new episode exploring the latest clinical data on RA treatment after TNFi failure. Before that episode drops, revisit their 2025 conversation on disease control, real-world data, and guidelines that inform clinical decision-making after TNFi failure. Sponsored by AbbVie Medical Affairs + Health Impact.
×